minocycline and ramelteon

As drug therapy experts, pharmacists are often called upon for facts and opinions about recently introduced drugs. New drugs are introduced at a rate that exceeds the reading time of many busy practitioners. This article is intended to provide an objective information and broad-based discussion about new drug options that have particular relevance for the elderly. Drugs that will be reviewed include: acamprosate, darifenacin, eszopiclone, exenatide, ibandronate, nitazoxanide, pramlintide, pregabalin, ramelteon, tigecycline, tinidazole, trospium, and solifenacin.

Topics: Advertising; Aged; Amyloid; Analgesics; Anti-Bacterial Agents; Azabicyclo Compounds; Clinical Trials as Topic; Drug Labeling; Exenatide; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Indenes; Islet Amyloid Polypeptide; Minocycline; Peptides; Piperazines; Pregabalin; Tigecycline; Venoms

Topics: Analgesics; Benzeneacetamides; Benzoates; Bone Density Conservation Agents; Deferasirox; Diphosphonates; Docosahexaenoic Acids; Drug Approval; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Eicosapentaenoic Acid; gamma-Aminobutyric Acid; Humans; Ibandronic Acid; Iloprost; Indenes; Minocycline; Patient Education as Topic; Phenylacetates; Pregabalin; Tigecycline; Triazoles; Vasodilator Agents

Topics: Dosage Forms; Drug Labeling; Humans; Indenes; Minocycline; Organoplatinum Compounds; Oxaliplatin; Pharmaceutical Preparations; Piperazines; Purines; Pyridines; Pyrones; Sildenafil Citrate; Sulfonamides; Sulfones; Tetanus Toxoid; Tigecycline; United States